All News

Developed countries may be able to assist developing countries in ensuring their drugs are safe.

A cell-editing platform allowed researchers to find genetic mutations that allow human immune cells to be resistant to HIV.

Top news of the day from across the health care landscape.

The Advisory Committee on Immunization Practices (ACIP) recommends all children aged 6 months through 8 years receive 2 influenza vaccine doses during their first vaccination season to ensure adequate immune response.

Testing method could improve radioembolization technique in cancer treatment.

New findings reveal that individuals who follow the Mediterranean diet may decrease the risk of age-related macular degeneration (AMD) by more than one-third.

Newly-discovered compound blocks an essential protein in sustaining tumor growth.

Removing proteins from the surface of secretory granules can potentially prevent anaphylactic shock.

Variants identify areas of the genome associated with multiple sclerosis.

A chronic lung infection from Pseudomonas aeruginosa can be drug-resistant and cause lung tissue damage.

Top articles of the week on Specialty Pharmacy Times.

Orencia is the only CTLA-4lg approved in the United States, European Union, and Japan for the treatment of rheumatoid arthritis.

Orencia is a fusion protein and the only CTLA-4lg approved in the United States for the treatment of rheumatoid arthritis.

Top news of the day from across the healthcare landscape.

Risk of AMD reduced by more than one-third in individuals who closely follow a Mediterranean diet rich in fruit.

The nomogram can predict risk of readmission to the surgical intensive unit.

Momenta and Mylan have announced that dosing has begun in a phase 1 study for M834, the proposed biosimilar of Orencia (abatacept).

The holiday season is a great time for pharmacists to educate patients on ways to stay healthy.

Biosimilars have been in the news quite a bit lately. Here’s an update on some of the big developments related to biosimilar development, approval, and regulations

Stay in the know with the hottest news in pharmacy this week.

The results of a recent study have suggested that parents use flavored sprays when their children have difficulty swallowing pills.

Compounded drugs accounted for more than half of cost increases under Medicare Part D in the last year.

Descovy showed non-inferiority to Truvada, and benefited bone and kidney health.

Older patients understood medication information more if it included pictograms.

Keytruda approved as a first-line treatment for non-small cell lung cancer.

Vaccine candidates for hepatitis C virus have been notoriously unsuccessful in preventing the infection.

Swedish study suggests that more American men can opt surveillance over prostate cancer treatment.

Astellaas Pharma has entered into an agreement to acquire Ganymed and its investigational cancer antibodies.

Triolimus contains paclitaxel plus 2 agents to prevent chemotherapy resistance.

Injections of nanoliposomes reversed memory loss associated with Alzheimer’s disease in mouse models.